● Investor

Adjuvant Capital

Life sciences impact fund backing drugs, vaccines, diagnostics and medical devices to address critical global public health challenges

Impact InvestingBoston, United States

Portfolio

1

companies tracked

Rounds · 12mo

0

participated in

Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.

—

sum of tracked rounds

Top stage

—

by round count

Recent activity

Rounds LatestRounds has tracked from this investor.

54GeneLagos, Nigeria
Series B$25MSep 16
54GeneLagos, Nigeria
Series A$15MApr 14